253 related articles for article (PubMed ID: 32530506)
1. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
Pan K; Chlebowski RT; Mortimer JE; Gunter MJ; Rohan T; Vitolins MZ; Adams-Campbell LL; Ho GYF; Cheng TD; Nelson RA
Cancer; 2020 Aug; 126(16):3638-3647. PubMed ID: 32530506
[TBL] [Abstract][Full Text] [Related]
2. Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative.
Pan K; Nelson RA; Wactawski-Wende J; Lee DJ; Manson JE; Aragaki AK; Mortimer JE; Phillips LS; Rohan T; Ho GYF; Saquib N; Shadyab AH; Nassir R; Rhee JJ; Hurria A; Chlebowski RT
J Natl Cancer Inst; 2020 Feb; 112(2):170-178. PubMed ID: 31184362
[TBL] [Abstract][Full Text] [Related]
3. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk in metabolically healthy but overweight postmenopausal women.
Gunter MJ; Xie X; Xue X; Kabat GC; Rohan TE; Wassertheil-Smoller S; Ho GY; Wylie-Rosett J; Greco T; Yu H; Beasley J; Strickler HD
Cancer Res; 2015 Jan; 75(2):270-4. PubMed ID: 25593034
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
[TBL] [Abstract][Full Text] [Related]
6. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population.
Arshi B; Tohidi M; Derakhshan A; Asgari S; Azizi F; Hadaegh F
J Hum Hypertens; 2015 Apr; 29(4):260-7. PubMed ID: 25355008
[TBL] [Abstract][Full Text] [Related]
8. Insulin Resistance and Risk of Cardiovascular Disease in Postmenopausal Women: A Cohort Study From the Women's Health Initiative.
Schmiegelow MD; Hedlin H; Stefanick ML; Mackey RH; Allison M; Martin LW; Robinson JG; Hlatky MA
Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):309-16. PubMed ID: 25944628
[TBL] [Abstract][Full Text] [Related]
9. Cardiometabolic risk factors, physical activity, and postmenopausal breast cancer mortality: results from the Women's Health Initiative.
Dieli-Conwright CM; Nelson RA; Simon MS; Irwin ML; Neuhouser ML; Reding KW; Crane TE; Manson JE; Nassir R; Shadyab AH; LaMonte M; Qi L; Thomson CA; Kroenke CH; Pan K; Chlebowski RT; Mortimer J
BMC Womens Health; 2022 Feb; 22(1):32. PubMed ID: 35120497
[TBL] [Abstract][Full Text] [Related]
10. Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.
Kabat GC; Kim MY; Lane DS; Zaslavsky O; Ho GYF; Luo J; Nicholson WK; Chlebowski RT; Barrington WE; Vitolins MZ; Lin X; Liu S; Rohan TE
Eur J Cancer Prev; 2018 May; 27(3):261-268. PubMed ID: 29438162
[TBL] [Abstract][Full Text] [Related]
11. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
[TBL] [Abstract][Full Text] [Related]
12. Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.
Chlebowski RT; Aragaki AK; Anderson GL; Pan K; Neuhouser ML; Manson JE; Thomson CA; Mossavar-Rahmani Y; Lane DS; Johnson KC; Wactawski-Wende J; Snetselaar L; Rohan TE; Luo J; Barac A; Prentice RL;
J Clin Oncol; 2020 May; 38(13):1419-1428. PubMed ID: 32031879
[TBL] [Abstract][Full Text] [Related]
13. Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.
Iyengar NM; Arthur R; Manson JE; Chlebowski RT; Kroenke CH; Peterson L; Cheng TD; Feliciano EC; Lane D; Luo J; Nassir R; Pan K; Wassertheil-Smoller S; Kamensky V; Rohan TE; Dannenberg AJ
JAMA Oncol; 2019 Feb; 5(2):155-163. PubMed ID: 30520976
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
Yuan Y; Pan K; Mortimer J; Chlebowski RT; Luo J; Yan JE; Yost SE; Kroenke CH; Adams-Campbell L; Nassir R; Sun Y; Shadyab AH; Vitolins MZ; Saquib N; Wild RA; Manson JE; Nelson RA
Cancer; 2021 May; 127(10):1658-1667. PubMed ID: 33476042
[TBL] [Abstract][Full Text] [Related]
15. Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.
Simon MS; Beebe-Dimmer JL; Hastert TA; Manson JE; Cespedes Feliciano EM; Neuhouser ML; Ho GYF; Freudenheim JL; Strickler H; Ruterbusch J; Barac A; Chlebowski R; Caan B
Cancer; 2018 Apr; 124(8):1798-1807. PubMed ID: 29338086
[TBL] [Abstract][Full Text] [Related]
17. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
Park NJ; Chang Y; Bender C; Conley Y; Chlebowski RT; van Londen GJ; Foraker R; Wassertheil-Smoller S; Stefanick ML; Kuller LH
PLoS One; 2017; 12(9):e0184174. PubMed ID: 28934233
[TBL] [Abstract][Full Text] [Related]
19. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.
Song Y; Manson JE; Tinker L; Howard BV; Kuller LH; Nathan L; Rifai N; Liu S
Diabetes Care; 2007 Jul; 30(7):1747-52. PubMed ID: 17468352
[TBL] [Abstract][Full Text] [Related]
20. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
